Qiming U.S. Healthcare Fund II, L.P. Insider Profile
4 Followers
Qiming U.S. Healthcare Fund II, L.P., Ten Percent Owner at Elevation Oncology, holds 8.52M shares in Jasper Therapeutics (Ticker: JSPR), holds 3.52M shares in Icosavax (Ticker: ICVX), holds 2.37M shares in Elevation Oncology (Ticker: ELEV). Most recently, Qiming U.S. Healthcare Fund II, L.P. Bought ― shares of Jasper Therapeutics on Apr 11, 2023 for an estimated value of 4.00M.
Qiming U.S. Healthcare Fund II, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Qiming U.S. Healthcare Fund II, L.P.?
The percentage of profitable transactions made by Qiming U.S. Healthcare Fund II, L.P. is 0%.
What is the average return per transaction made by Qiming U.S. Healthcare Fund II, L.P.?
The average return per transaction made by Qiming U.S. Healthcare Fund II, L.P. is -81.40%.
What stocks does Qiming U.S. Healthcare Fund II, L.P. hold?
Qiming U.S. Healthcare Fund II, L.P. holds: ELEV, ICVX, JSPR stocks.
What was Qiming U.S. Healthcare Fund II, L.P.’s latest transaction?
Qiming U.S. Healthcare Fund II, L.P. latest transaction was an Informative Buy of $4.00M.
What was Qiming U.S. Healthcare Fund II, L.P.'s most profitable transaction?
Qiming U.S. Healthcare Fund II, L.P.’s most profitable transaction was an Informative Buy of ICVX stock on August 2, 2021. The return on the trade was -73.90%.
What is Qiming U.S. Healthcare Fund II, L.P.'s role in Elevation Oncology?
Qiming U.S. Healthcare Fund II, L.P.'s role in Elevation Oncology is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.